COUR
"COUR" is a word mark owned by Cour Pharmaceuticals Development Co., Inc., filed at the USPTO on September 10, 2026. It is under examination and covers classes 5 and 42.
- Status
- Under examination
- Since September 10, 2026
- Filed
- September 10, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50101237
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 2 classes
Who owns COUR
The owner and representative on file with the office.
Owner
Cour Pharmaceuticals Development Co., Inc.
Evanston, United States
Representative
Gregory J. Chinlund
Marshall, Gerstein & Borun LLP
What the mark covers
The products and services COUR is filed for, grouped by Nice class.
nanoparticles; pharmaceutical preparations for treatment of immune system disorders, autoimmune diseases, and inflammatory diseases
research in the field of immune tolerance; pharmaceutical research and development in the field of immune system disorders and autoimmune diseases and inflammatory diseases
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application entered
About COUR
Who owns the trademark "COUR"?
The USPTO trademark "COUR" (application 50101237) is owned by Cour Pharmaceuticals Development Co., Inc.
What is the status of "COUR"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull COUR and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a09097-7e12-716c-85f8-c70671d996b0
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a09097-7e12-716c-85f8-c70671d996b0",
"object": "trademark",
"mark_text": "COUR",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50101237",
"filing_date": "2026-09-10",
"nice_classes": [
5,
42
],
"owners": [
{
"name": "Cour Pharmaceuticals Development Co., Inc.",
"entity_id": null
}
]
}